Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Merck & Co., Inc. MRK NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
83/100
7/7 Pass
SharesGrow Intrinsic Value
$187.77
+56.5%
Analyst Price Target
$128.54
+7.2%
Metric TTM (2025-03 – 2025-12)
Revenue $65.01B
Gross Profit $52.98B
Gross Margin 81.5%
Operating Income $26.78B
Net Income $18.25B
Net Margin 28.1%
EPS (Diluted) $7.28

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 TMO
TMO
Thermo Fisher Scientific Inc.
$527.22
+2.53%
 AMGN
AMGN
Amgen Inc.
$350.95
+0.32%
 ABT
ABT
Abbott Laboratories
$101.07
+0.38%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message